NCT05511428 2025-11-21Home Based Daratumumab Administration for Patients With Multiple MyelomaThomas Jefferson UniversityPhase 4 Completed20 enrolled 38 charts
NCT03768960 2025-02-03A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory AgentJohnson & Johnson Private LimitedPhase 4 Completed150 enrolled